정책동향
The 2008 R&D Scoreboard : Pharmaceuticals & Biotechnology
- 등록일2009-03-03
- 조회수9347
- 분류정책동향 > 기타 > 기타
-
자료발간일
2009-01-14
-
출처
BERR
-
원문링크
-
키워드
#Scoreboard #Pharmaceuticals#Biotechnology
- 첨부파일
The_2008_R&D_Scoreboard.pdf
The 2008 R&D Scoreboard
Pharmaceuticals & Biotechnology
Highlights
○ The pharmaceuticals & biotechnology sector was the largest contributor to R&D in both
the UK850 and the G1400 in 2007.
○ Eight of the top 25 R&D investors globally are pharmaceuticals companies: they include two
UK firms, GlaxoSmithKline and Astra Zeneca.
○ GlaxoSmithKline and AstraZeneca dominate R&D spend in the UK pharmaceuticals sector:
they spent (89% of the sector total, and 37% of the UK850 spend).
○ Sixteen more pharmaceuticals & biotechnology companies entered the UK850 bringing the
total to 130.
○ R&D in the pharmaceuticals & biotechnology industry continues to grow more quickly than
sales amongst the largest investors.
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.
관련정보
동향
- 산업동향 The Pharmaceutical Industry in a Global Economy: What Drives EU Exports of Pharmaceuticals Overseas 2014-11-13
- 정책동향 Innovation Union Scoreboard 2014 2014-04-08
- 산업동향 EU R&D Scoreboard : The 2013 EU Industrial R&D Investment Scoreboard 2013-11-26
- 정책동향 EU R&D Scoreboard : The 2012 EU Industrial R&D Investment Scoreboard 2013-01-02
- 정책동향 Innovation Union Scoreboard 2011 2012-02-21